Found: 17
Select item for more details and to access through your institution.
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program.
- Published in:
- Pituitary, 2021, v. 24, n. 4, p. 611, doi. 10.1007/s11102-021-01138-3
- By:
- Publication type:
- Article
An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies.
- Published in:
- Pituitary, 2020, v. 23, n. 4, p. 347, doi. 10.1007/s11102-020-01038-y
- By:
- Publication type:
- Article
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ.
- Published in:
- Pituitary, 2019, v. 22, n. 6, p. 581, doi. 10.1007/s11102-019-00986-4
- By:
- Publication type:
- Article
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2023, v. 108, n. 5, p. e148, doi. 10.1210/clinem/dgac643
- By:
- Publication type:
- Article
Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2020, v. 105, n. 4, p. e1358, doi. 10.1210/clinem/dgaa049
- By:
- Publication type:
- Article
Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.
- Published in:
- Endocrine (1355008X), 2018, v. 61, n. 1, p. 105, doi. 10.1007/s12020-018-1615-3
- By:
- Publication type:
- Article
Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations.
- Published in:
- Clinical Diabetes & Endocrinology, 2020, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40842-020-00105-4
- By:
- Publication type:
- Article
Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER.
- Published in:
- Journal of the Endocrine Society, 2023, v. 7, n. 6, p. 1, doi. 10.1210/jendso/bvad054
- By:
- Publication type:
- Article
Patients with Acromegaly Presenting with Colon Cancer: A Case Series.
- Published in:
- Case Reports in Endocrinology, 2016, p. 1, doi. 10.1155/2016/5156295
- By:
- Publication type:
- Article
Occult Langerhans Cell Histiocytosis Presenting with Papillary Thyroid Carcinoma, a Thickened Pituitary Stalk and Diabetes Insipidus.
- Published in:
- Case Reports in Endocrinology, 2016, p. 1, doi. 10.1155/2016/5191903
- By:
- Publication type:
- Article
Risk-based engineering design for a landfill leachate collection andliner system
- Published in:
- Ground Water Monitoring & Remediation, 1996, v. 16, n. 2, p. 139
- By:
- Publication type:
- Article
Estimation of leakage rates through flexible membrane liners
- Published in:
- Ground Water Monitoring & Remediation, 1995, v. 15, n. 4, p. 148
- By:
- Publication type:
- Article
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.662865
- By:
- Publication type:
- Article
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands.
- Published in:
- Frontiers in Endocrinology, 2021, v. 11, p. N.PAG, doi. 10.3389/fendo.2021.627711
- By:
- Publication type:
- Article